Cargando…
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
Type 2 diabetes is a leading cause of chronic kidney disease worldwide and continues to increase in prevalence. This in turn has significant implications for healthcare provision and the economy. In recent years there have been multiple advances in the glucose-lowering agents available for the treat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165820/ https://www.ncbi.nlm.nih.gov/pubmed/34104399 http://dx.doi.org/10.1177/20420188211020664 |